Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonparametric estimation and testing in a cure model.

E M Laska1, M J Meisner

  • 1Statistical Sciences and Epidemiology Division, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York 10962.

Biometrics
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prevalence and correlates of untreated serious mental illness.

Health services research·2002
Same author

Statistical cost-effectiveness analysis of two treatments based on net health benefits.

Statistics in medicine·2001
Same author

Assessing the onset of relief of a treatment for migraine.

Cephalalgia : an international journal of headache·2001
Same author

Power and sample size in cost-effectiveness analysis.

Medical decision making : an international journal of the Society for Medical Decision Making·1999
Same author

Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence.

Health economics·1999
Same author

The usefulness of average cost-effective ratios.

Health economics·1997
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

This study introduces new statistical methods for estimating cure rates in medical studies with random censoring. The developed likelihood ratio tests offer a powerful tool for comparing treatment effectiveness in clinical trials.

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Clinical Trial Methodology

Background:

  • Estimating cure rates in the presence of random censorship is crucial for evaluating treatment efficacy.
  • Existing methods may lack sufficient power or flexibility for certain clinical trial designs.

Purpose of the Study:

  • To develop and evaluate nonparametric generalized maximum likelihood estimators for cure models with random censorship.
  • To introduce and assess the performance of one-, two-, and K-sample likelihood ratio tests for cure rate inference.
  • To compare the power of the proposed likelihood ratio tests against established methods in two-sample scenarios.

Main Methods:

  • Nonparametric generalized maximum likelihood product limit point estimation.
  • Development of one-, two-, and K-sample likelihood ratio tests.

Related Experiment Videos

  • Power comparison with log-rank and Gray and Tsiatis tests.

    • Main Results:

    • The study provides robust estimators and confidence intervals for cure rates under random censorship.
    • Likelihood ratio tests are developed for comparing cure rates across multiple samples.
    • The proposed tests demonstrate competitive or superior power compared to existing methods in simulations.

    Conclusions:

    • The developed likelihood ratio tests are effective for comparing cure rates in clinical trials.
    • These methods offer a valuable addition to the statistical toolkit for survival data analysis.
    • The findings have direct implications for the design and analysis of clinical trials focusing on cure outcomes.